#72Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Cannabinoid hyperemesis syndrome represents an increasingly recognized clinical entity that clinicians must identify to avoid unnecessary diagnostic workups and ineffective interventions in chronic cannabis users presenting with intractable nausea and vomiting. Early recognition of CHS’s pathognomonic symptom cluster—cyclical vomiting with paradoxical relief from hot water immersion—enables appropriate counseling on the sole evidence-based intervention: complete cannabis cessation. Given rising cannabis use prevalence and potency, CHS screening should become routine in patients with unexplained hyperemesis, particularly those with daily or near-daily consumption patterns.
Cannabis hyperemesis syndrome (CHS) is a paradoxical condition affecting chronic heavy users characterized by cyclical episodes of severe nausea, vomiting, and abdominal pain that temporarily resolve with hot water exposure, despite cannabis’s recognized antiemetic properties in other populations. The syndrome is strongly associated with long-term, high-frequency use of high-potency THC products, though the underlying pathophysiologic mechanism remains incompletely understood. While no controlled trials comparing treatment modalities are cited in this clinical overview, the literature supports complete cannabis cessation as the only reliably effective treatment for CHS. Physicians should maintain clinical suspicion for CHS in patients presenting with recurrent vomiting and the characteristic history of symptom relief with hot showers, particularly those reporting daily or near-daily cannabis use. Given the increasing potency of cannabis products available to consumers and rising prevalence of CHS cases, obtaining detailed substance use histories focusing on frequency and potency of cannabis consumption should be part of the evaluation for patients with unexplained nausea and vomiting. Patients with suspected CHS should be counseled that complete abstinence from cannabis is necessary to achieve sustained symptom resolution.
“I’m seeing CHS cases with increasing frequency in my practice, particularly among patients who’ve been using high-potency products daily for years, and while the mechanism isn’t completely understood, the clinical pattern is unmistakable: compulsive bathing, intractable nausea, and vomiting that resolves only with complete cessation. The challenge is that many patients resist stopping entirely, so my role is to be honest that we don’t have a pharmacological workaround here, only abstinence works, though some patients benefit from lower doses or switching consumption methods while they’re tapering.”
🌿 Cannabis hyperemesis syndrome represents a paradoxical and increasingly recognized condition among chronic cannabis users, characterized by cyclical episodes of severe nausea and vomiting that characteristically improve with hot showers or baths. While the exact pathophysiologic mechanism remains unclear, the condition appears related to cumulative cannabinoid exposure and the dysregulation of the endocannabinoid system’s thermoregulatory and gastrointestinal functions. It is important to recognize that CHS can mimic other serious conditions such as gastroenteritis, cyclic vomiting syndrome, or inflammatory bowel disease, which may lead to unnecessary investigations and delayed diagnosis if the cannabis use history is not thoroughly explored during the clinical evaluation. The definitive and only reliably effective treatment is complete cessation of cannabis use, making early identification critical for patient counseling and prevention of complications such as dehydration and electrolyte abnormalities.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: